Treatment for hemophilia can now be administered via a biodegradable, pH-responsive hydrogel microcarrier system, a capsule, thanks to a breakthrough by researchers at the University of Texas at Austin. They describe their system in the Nov. 30, 2016 issue of the International Journal of Pharmaceutics. Illustration of the degradable system carrying treatment for hemophilia B. Image credit: University of Texas at Austin. There are about 400,000 people...
